Cite
Supplemental Table 5 from Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA
MLA
Erica L. Carpenter, et al. Supplemental Table 5 from Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8e7a95671781e39b3f2ad3b481c8edc4&authtype=sso&custid=ns315887.
APA
Erica L. Carpenter, Anil Vachani, Corey Langer, Elizabeth Gilbert, Victoria E. Sherry, Susan Stonehouse-Lee, Stephen Bagley, Roger B. Cohen, Christine Ciunci, Evan Alley, John A. Kosteva, Charu Aggarwal, Joshua Bauml, Tracey L. Evans, Jennifer D. Morrissette, David B. Lieberman, David Balli, Ryan Fan, Samantha L. Savitch, … Jeffrey C. Thompson. (2023). Supplemental Table 5 from Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA.
Chicago
Erica L. Carpenter, Anil Vachani, Corey Langer, Elizabeth Gilbert, Victoria E. Sherry, Susan Stonehouse-Lee, Stephen Bagley, et al. 2023. “Supplemental Table 5 from Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8e7a95671781e39b3f2ad3b481c8edc4&authtype=sso&custid=ns315887.